Lipoplexes' Structure, Preparation, and Role in Managing Different Diseases

Area of Science:

• Biomedical Engineering
• Gene Therapy
• Nanotechnology

Background:

• Lipid-based vectors, particularly cationic lipids, are emerging as key non-viral vectors for gene delivery.
• Lipoplex-based gene therapy is gaining traction, evidenced by numerous clinical trials.
• Traditional therapies are being supplemented by these advanced vector systems for critical diseases like cancer.

Purpose of the Study:

• To review the advancements and potential of lipid-based vectors in gene delivery.
• To highlight the advantages of lipoplexes over viral vectors in therapeutic applications.
• To discuss the factors influencing lipoplex efficiency and the importance of understanding design principles.

Main Methods:

• Literature review of lipid-based gene delivery systems.
• Analysis of clinical trial data for lipoplex-based therapies.
• Exploration of functional lipids for enhancing nucleic acid delivery.

Main Results:

• Lipid-based vectors offer reduced toxicity and immunogenicity compared to viral vectors.
• Lipoplexes can be engineered for targeted delivery and large-scale production.
• Functional lipids present opportunities to improve nucleic acid-lipid interactions and delivery efficiency.

Conclusions:

• Lipid-based vectors, especially lipoplexes, are a promising platform for gene therapy, particularly for cancer treatment.
• Further research into lipoplex design principles is crucial for developing effective, customized formulations.
• Optimizing factors like structure, stability, and internalization will enhance transfection efficiency for biomedical applications.